DE, dermis (containing aged NHDF) strength and cohesion (basal)| Type of assay | ECM synthesis/degradation | | Biological model | | | Species | Human | | Endpoint | Lattices contraction |
| DE-0014 | Intrinsic aging (dermis) | ECM synthesis/degradation | | Human | Lattices contraction | Imaging | Basal | |
DPF, testosterone metabolism & 5- alpha reductase activity (basal)| Type of assay | Androgen metabolism | | Biological model | Human Follicle Dermal Papilla Cells(HFDPC) | | Species | Human | | Endpoint | 5- alpha reductase activity |
| DPF-0001 | Hair growth & degeneration | Androgen metabolism | Human Follicle Dermal Papilla Cells(HFDPC) | Human | 5- alpha reductase activity | [14C]-testosterone incorporation | Basal | |
Epidermis/Dermis, keratinocyte migration (basal)| Type of assay | Proliferation and/or migration | | Biological model | Normal skin epidermis onto a dermis-equivalent | | Species | Human | | Endpoint | Migration (+ proliferation) |
| EPI&DE-0001 | Wound healing, trauma & agressions, Wound healing, trauma & aggressions, Proliferation, migration, re-epithelialization | Proliferation and/or migration | Normal skin epidermis onto a dermis-equivalent | Human | Migration (+ proliferation) | Imaging | Basal | |
RHE, sirtuin 1 expression (basal)| Type of assay | Metabolism | | Biological model | Reconstructed Epidermis, BIOalternatives RHE | | Species | Human | | Endpoint | Sirtuin 1 immunolabeling |
| EPIBA-0012 | Keratinocyte viability & metabolism | Metabolism | Reconstructed Epidermis, BIOalternatives RHE | Human | Sirtuin 1 immunolabeling | Immunohistofluorescence | Basal | |
RHE, mitochondrial dehydrogenase activity (basal)| Type of assay | Metabolism | | Biological model | Reconstructed Epidermis, BIOalternatives RHE | | Species | Human | | Endpoint | MTT reduction |
| EPIBA-0016 | Keratinocyte viability & metabolism | Metabolism | Reconstructed Epidermis, BIOalternatives RHE | Human | MTT reduction | Photometry | Basal | |
RHE, ATP content (basal)| Type of assay | Metabolism | | Biological model | Reconstructed Epidermis, BIOalternatives RHE | | Species | Human | | Endpoint | ATP |
| EPIBA-0017 | Keratinocyte viability & metabolism | Metabolism | Reconstructed Epidermis, BIOalternatives RHE | Human | ATP | Luminescence | Basal | |
RHE, Ki67 expression (proliferation marker) (basal)| Type of assay | Protein markers | | Biological model | Reconstructed Epidermis, BIOalternatives RHE | | Species | Human | | Endpoint | Ki67 |
| EPIBA-0018 | Proliferation, migration, re-epithelialization | Protein markers | Reconstructed Epidermis, BIOalternatives RHE | Human | Ki67 | Immunohistofluorescence or IHC | Basal | |
RHE, [14C]-caffein diffusion (basal)| Type of assay | Barrier function | | Biological model | Reconstructed Epidermis, BIOalternatives RHE | | Species | Human | | Endpoint | [14C]-caffein diffusion (long protocol; kinetic) |
| EPIBA-0019 | Differentiation, protection, barrier function | Barrier function | Reconstructed Epidermis, BIOalternatives RHE | Human | [14C]-caffein diffusion (long protocol; kinetic) | Radioactivity | Basal | |
RHE, TGK activity in epidermis (basal)| Type of assay | Protein markers | | Biological model | Reconstructed Epidermis, BIOalternatives RHE | | Species | Human | | Endpoint | Transglutaminase 1 activity |
| EPIBA-0020 | Differentiation, protection, barrier function | Protein markers | Reconstructed Epidermis, BIOalternatives RHE | Human | Transglutaminase 1 activity | Radiobiochemical | Basal | |
RHE, differentiation marker expression (basal)| Type of assay | Protein markers | | Biological model | Reconstructed Epidermis, BIOalternatives RHE | | Species | Human | | Endpoint | Expression of e.g. filaggrin, TGK, cytokeratin 10, loricrin... |
| EPIBA-0021 | Differentiation, protection, barrier function | Protein markers | Reconstructed Epidermis, BIOalternatives RHE | Human | Expression of e.g. filaggrin, TGK, cytokeratin 10, loricrin... | Immunohistofluorescence or IHC | Basal | |
RHE, mRNA for differentiation markers (basal)| Type of assay | Gene expression | | Biological model | Reconstructed Epidermis, BIOalternatives RHE | | Species | Human | | Endpoint | mRNA: e.g. FLG, TGM1, KRT10, LOR…, mQPA-NHEK-16, mQPA-NHEK-32, mQPA-NHEK-64 |
| EPIBA-0022 | Differentiation, protection, barrier function | Gene expression | Reconstructed Epidermis, BIOalternatives RHE | Human | mRNA: e.g. FLG, TGM1, KRT10, LOR…, mQPA-NHEK-16, mQPA-NHEK-32, mQPA-NHEK-64 | RT-qPCR, qPCRarray (standard or customized) | Basal | |
RHE, total lipid & ceramide neosynthesis (basal)| Type of assay | Lipid synthesis | | Biological model | Reconstructed Epidermis, BIOalternatives RHE | | Species | Human | | Endpoint | Total lipid & ceramide neosynthesis |
| EPIBA-0024 | Differentiation, protection, barrier function | Lipid synthesis | Reconstructed Epidermis, BIOalternatives RHE | Human | Total lipid & ceramide neosynthesis | [14C]-acetate incorporation in polar lipids + TLC | Basal | |
RHE, total lipids & ceramide neosynthesis (Vitamin C stimulation)| Type of assay | Lipid synthesis | | Biological model | Reconstructed Epidermis, BIOalternatives RHE | | Species | Human | | Endpoint | Total lipid & ceramide neosynthesis |
| EPIBA-0025 | Differentiation, protection, barrier function | Lipid synthesis | Reconstructed Epidermis, BIOalternatives RHE | Human | Total lipid & ceramide neosynthesis | [14C]-acetate incorporation in polar lipids + TLC | Vitamin C | |
RHE, hyaluronic acid synthesis / release (basal)| Type of assay | GAG synthesis | | Biological model | Reconstructed Epidermis, BIOalternatives RHE | | Species | Human | | Endpoint | Hyaluronic acid synthesis / release |
| EPIBA-0028 | Epidermal matrix, hydration | GAG synthesis | Reconstructed Epidermis, BIOalternatives RHE | Human | Hyaluronic acid synthesis / release | ELISA / EIA | Basal | |
RHE, total GAGs neosynthesis (basal)| Type of assay | GAG synthesis | | Biological model | Reconstructed Epidermis, BIOalternatives RHE | | Species | Human | | Endpoint | Glycosaminoglycans (GAGs, total) |
| EPIBA-0029 | Epidermal matrix, hydration | GAG synthesis | Reconstructed Epidermis, BIOalternatives RHE | Human | Glycosaminoglycans (GAGs, total) | [3H]-glucosamine incorporation | Basal | |
RHE, sulfated GAGs neosynthesis (basal)| Type of assay | GAG synthesis | | Biological model | Reconstructed Epidermis, BIOalternatives RHE | | Species | Human | | Endpoint | Sulfated glycosaminoglycans (sulfated GAGs) |
| EPIBA-0030 | Epidermal matrix, hydration | GAG synthesis | Reconstructed Epidermis, BIOalternatives RHE | Human | Sulfated glycosaminoglycans (sulfated GAGs) | Sulfur-35 (35S) incorporation | Basal | |
RHE, hyaluronic acid expression (basal)| Type of assay | GAG synthesis | | Biological model | Reconstructed Epidermis, BIOalternatives RHE | | Species | Human | | Endpoint | Hyaluronic acid immunolabeling |
| EPIBA-0031 | Epidermal matrix, hydration | GAG synthesis | Reconstructed Epidermis, BIOalternatives RHE | Human | Hyaluronic acid immunolabeling | Immunohistofluorescence | Basal | |
RHE, protein markers (PGs, ECM receptors...) expression (basal)| Type of assay | Protein markers | | Biological model | Reconstructed Epidermis, BIOalternatives RHE | | Species | Human | | Endpoint | Expression of e.g. CD44, alpha2 beta1 integrin... |
| EPIBA-0032 | Epidermal matrix, hydration | Protein markers | Reconstructed Epidermis, BIOalternatives RHE | Human | Expression of e.g. CD44, alpha2 beta1 integrin... | Immunohistofluorescence or IHC | Basal | |
RHE, mRNA for epidermal matrix-related proteins (basal)| Type of assay | Gene expression | | Biological model | Reconstructed Epidermis, BIOalternatives RHE | | Species | Human | | Endpoint | mRNA: e.g. CD44, HAS3, integrins, PGs…, mQPA-NHEK-BARRIER-16 |
| EPIBA-0033 | Epidermal matrix, hydration | Gene expression | Reconstructed Epidermis, BIOalternatives RHE | Human | mRNA: e.g. CD44, HAS3, integrins, PGs…, mQPA-NHEK-BARRIER-16 | RT-qPCR, qPCRarray (standard or customized) | Basal | |
RHE, dermo-epidermal junction protein expression (basal)| Type of assay | Protein markers | | Biological model | Reconstructed Epidermis, BIOalternatives RHE | | Species | Human | | Endpoint | other (inquire), Expression of e.g. laminin 5, Collagens IV, VII… |
| EPIBA-0035 | Epidermal cohesion, dermo-epidermal junction | Protein markers | Reconstructed Epidermis, BIOalternatives RHE | Human | other (inquire), Expression of e.g. laminin 5, Collagens IV, VII… | Immunohistofluorescence or IHC | Basal | |